Retrospective analysis of pre and post-Enhanced Recovery after Surgery for Total mastectomy pathway implementation.
Retrospective analysis of pre- and post-Enhanced Recovery after surgery for total mastectomy pathway implementation in patients at Mount Zion Hospital. We examined perioperative opioid consumption, pain scores, post-operative nausea and vomiting, benzodiazepine use, length of stay for the time period before and after implementation of an Enhanced Recovery after Surgery pathway for Total mastectomy. Pathway features included preoperative acetaminophen and gabapentin, minimizing opioids, postoperative NSAIDs, Pecs blocks, and aggressive postoperative nausea and vomiting prophylaxis.
Study Type
OBSERVATIONAL
Enrollment
386
Enhanced Recovery after Surgery (ERAS) pathway for Total Mastectomy
perioperative opioid consumption
perioperative opioid consumption
Time frame: through study completion (average of 1 year)
Post-operative nausea and vomiting (PONV)
incidence post-operative nausea and vomiting
Time frame: through study completion (average of 1 year)
postoperative benzodiazepine use
amount of benzodiazepines used postoperatively for treatment of muscle spasm
Time frame: through study completion (average of 1 year)
Length of stay (LOS)
Length of stay
Time frame: through study completion (average of 1 year)
Pain score
highest pain score perioperatively
Time frame: through study completion (average of 1 year)
Surgery duration
length of surgery (min)
Time frame: through study completion (average of 1 year)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.